Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks0Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by cancer family

Pancreas16Breast32Prostate29Lung and pleura38Colorectal23Esophagus and stomach20Liver, bile duct and gallbladder29Kidney and bladder42Brain and nervous system38Blood, lymph and bone marrow38Skin and eye28Head and neck13Thyroid and endocrine8Gynecologic28Sarcoma and soft tissue22Germ cell and testis3Thymus3Multiple or not classified from the title48
Plans & pricingCompare EvidenceHelix workspace plans
Library›Cancer study catalog›Prostate

Cancer family · grouped by EvidenceHelix from study titles

Prostate: 29 studies

Public cancer genomics studies in this group, with the collection each belongs to. Open a study for its description, citation and original source links.

  • Metastatic castration-sensitive prostate cancer (MSK, Clin Cancer Res 2020)

    MSK-IMPACT sequencing of 424 matched tumor-normal samples from patients with metastatic castration-sensitive prostate cancer. Germline alterations are not shown here.

    ProstateMSK studiesSource code pradPubMed 1
  • Metastatic Prostate Adenocarcinoma (MCTP, Nature 2012)

    Exome sequencing of 61 prostate cancer tumor/normal pairs (50 metastatic CRPCs and 11 high-grade localized prostate cancers). Generated by Arul Chinnaiyan's and Scott Tomlins' labs at the University of Michigan.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Metastatic Prostate Adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)

    Whole exome sequencing of 444 castrate resistant prostate cancer tumor/normal pairs. SU2C-PCF Dream Team: Precision Therapy for Advanced Prostate Cancer.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Metastatic Prostate Cancer (SU2C/PCF Dream Team, Cell 2015)

    Whole-exome sequencing of 150 metastatic prostate cancer tumor/normal pairs by the SU2C/PCF Dream Team.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Neuroendocrine Prostate Cancer (Multi-Institute, Nat Med 2016)

    Whole exome sequencing of 114 metastatic tumor/normal pairs to understand genomic overlap between castration resistant adenocarcinoma (CRPC-Adeno) and neuroendocrine histologies (CRPC-NE).

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (Broad/Cornell, Cell 2013)

    Whole genome sequencing of 57 prostate tumor and matches normal tissues.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (Broad/Cornell, Nat Genet 2012)

    Whole-exome sequencing of 112 prostate adenocarcinomas and matched normal samples. Generated by Levi Garraway's lab at the Broad Institute and Mark Rubin's lab at Cornell.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (CPC-GENE, Nature 2017)

    Whole-genome/exome sequencing of 477 prostate samples from CPC-GENE and public data sets, including TCGA-PRAD.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (Fred Hutchinson CRC, Nat Med 2016)

    Whole-exome sequencing, array comparative genomic hybridization (CGH) and RNA transcript profiling of 176 tumors from 63 patients with disseminated prostate cancer with matched normals.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (MSK, Cancer Cell 2010)

    Comprehensive profiling of 218 prostate tumors (181 primaries, 37 metastases) and 14 prostate cancer cell lines and xenografts. MSKCC Prostate Oncogenome Project. Normalized flat data files (http://cbio.mskcc.org/canc…

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (MSK, Clin Cancer Res. 2022)

    Targeted sequencing of 1417 Prostate Adenocarcinoma tumor/normal sample pairs via MSK-IMPACT to analyze the significance of PIK3R1 alterations.

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (MSK, Eur Urol 2020)

    Targeted sequencing of 1465 prostate adenocarcinoma tumor/normal pairs via MSK-IMPACT.

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (MSK, PNAS 2014)

    Genome-wide copy number profiling in 104 primary prostate cancer tumor/normal pairs. Raw data via GEO (GSE54691) (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54691).

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (MSK/DFCI, Nature Genetics 2018)

    Whole exome Sequencing of 1013 prostate cancer samples and their matched normals.

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (SMMU, Eur Urol 2017)

    Whole-genome and transcriptome sequencing of 65 Prostate Adenocarcinoma tumor/normal pairs.

    ProstateOther published and consortium studiesSource code pradPubMed 1
  • Prostate Adenocarcinoma (TCGA, Cell 2015)

    Whole exome and/or whole genome sequencing of 333 primary prostate adenocarcinoma tumor/normal pairs; raw data at the NCI (https://tcga-data.nci.nih.gov/docs/publications/prad_2015/).

    ProstateTCGA (other releases)Source code pradPubMed 1
  • Prostate Adenocarcinoma (TCGA, Firehose Legacy)

    TCGA Prostate Adenocarcinoma. Source data from GDAC Firehose (http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/PRAD/20160128/). Previously known as TCGA Provisional.

    ProstateTCGA Firehose LegacySource code prad
  • Prostate Adenocarcinoma (TCGA, PanCancer Atlas)

    Prostate Adenocarcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas/…

    ProstateTCGA PanCancer AtlasSource code pradPubMed 12
  • Prostate Adenocarcinoma Organoids (MSK, Cell 2014)

    Exome sequencing of 12 advanced prostate cancer samples and matched organoids

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Cancer (DKFZ, Cancer Cell 2018)

    Whole genome and transcriptome sequencing of tumor/normal pairs from 292 prostate cancer patients.

    ProstateOther published and consortium studiesSource code prostatePubMed 1
  • Prostate Cancer (MSK, Cell Metab 2020)

    MSK-IMPACT Sequencing of 18 prostate cancer tumor/normal pairs.

    ProstateMSK studiesSource code prostatePubMed 1
  • Prostate Cancer (MSK, Clin Cancer Res 2024)

    Targeted sequencing of 2,257 prostate cancer patient samples and their matched normals via MSK-IMPACT platform. This data is available under the Creative Commons BY-NC-ND 4.0 license (https://creativecommons.org/licen…

    ProstateMSK studiesSource code prostatePubMed 1
  • Prostate Cancer (MSK, JCO Precis Oncol 2017)

    IMPACT sequencing of 504 prostate cancer tumor/normal pairs.

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Cancer (MSK, Science 2022)

    Targeted sequencing and whole exome sequencing of 35 prostate cancer tumors, organoids and cell lines via MSK-IMPACT.

    ProstateMSK studiesSource code pradPubMed 1
  • Prostate Cancer Brain Metastases (Bern, Nat Commun. 2022)

    Prostate Cancer Brain Metastases, Switzerland. Dataset was generated in 2019 by Antonio Rodriguez, John Gallon, Salvatore Piscuoglio and Mark Rubin.

    ProstateOther published and consortium studiesSource code prostatePubMed 1
  • Prostate Cancer MDA PCa PDX (MD Anderson, Clin Cancer Res 2024)

    Targeted sequencing and whole-genome sequencing of 88 MD Anderson Prostate Cancer PDX models derived from 38 patients with tumor.

    ProstateOther published and consortium studiesSource code prostatePubMed 1
  • Prostate Cancer-IDH Driver Mutant Cohort (MSK, 2024)

    Targeted sequencing of 96 prostate cancer patients.

    ProstateMSK studiesSource code prad
  • Race Differences in Prostate Cancer (MSK, 2021)

    Targeted sequencing of 2,069 prostate cancers from different races via MSK-IMPACT.

    ProstateMSK studiesSource code pradPubMed 1
  • The Metastatic Prostate Cancer Project (Provisional, June 2021)

    The Metastatic Prostate Cancer Project is a patient-driven initiative. This study includes genomic data, cfDNA tumor fractions, patient-reported data (pre-pended as PRD), medical record data (MedR), and pathology repo…

    ProstateOther published and consortium studiesSource code prostate

Other families

  • Pancreas16 studies
  • Breast32 studies
  • Lung and pleura38 studies
  • Colorectal23 studies
  • Esophagus and stomach20 studies
  • Liver, bile duct and gallbladder29 studies
  • Kidney and bladder42 studies
  • Brain and nervous system38 studies
  • Blood, lymph and bone marrow38 studies
  • Skin and eye28 studies
  • Head and neck13 studies
  • Thyroid and endocrine8 studies
  • Gynecologic28 studies
  • Sarcoma and soft tissue22 studies
  • Germ cell and testis3 studies
  • Thymus3 studies
  • Multiple or not classified from the title48 studies

Study metadata from cBioPortal DataHub (e1b75cd25b, synced 2026-10-31), available under the ODC Open Database License (ODbL) 1.0; attribution required. EvidenceLib is a research-education resource, not medical advice. Sources & licence